Arcadia Biosciences Balance Sheet - Quarterly (NASDAQ:RKDA)

Add to My Stocks
$0.72 $0.01 (1.64%) RKDA stock closing price Apr 21, 2017 (Closing)

The fundamental analysis of this company requires a thorough look at Arcadia Biosciences balance sheet. How cash on hand has increased or decreased is one of the many indicators used while undertaking the Arcadia Biosciences stock analysis, and provides insights into the firm's financial performance. Quarterly results announcements include the release of all three financial statements, of which the balance sheet is one. Arcadia Biosciences had a long term debt of $25.12M at the end of 2016-Q4. Arcadia Biosciences operating cash flow was $-17.05M while Arcadia Biosciences revenue stood at $0.54M. View Arcadia Biosciences quarterly results to get the balance sheet details for the latest & last 40 quarters data..

show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3
Marketable Securities48.54M43.41M26.87M20.65M26.27M11.29M----
Raw Materials-------1.06M--
Work In Progress----------
Finished Goods-------1.56M--
Notes Receivable----------
Other Current Assets0.87M1.18M1.39M1.33M0.69M0.67M0.7M0.25M0.27M-
Arcadia Biosciences Total Current Assets
Property Plant & Equipment5.44M---5.24M---5.38M-
Accumulated Depreciation4.94M---4.65M---4.65M-
Arcadia Biosciences Net Property Plant & Equipment
Investment & Advances2.49M3.47M6.91M14.9M19.74M0.5M0.5M0.5M0.5M-
Other Non-Current Assets1.32M1.83M1.87M1.83M1.86M2.13M2.1M2.1M2.14M-
Deferred Charges----------
Deposits & Other Assets0.01M0.02M0.09M0.17M0.02M0.1M0.11M3.78M2.81M-
Arcadia Biosciences Total Assets
Notes Payable--5.6M4.56M------
Accounts Payable2.35M2.61M2.57M2.79M2.42M3.97M4.67M3.38M3.19M-
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses----------
Income Taxes Payable----------
Other Current Liabilities0.77M1.21M1.5M1.36M1.02M3.28M3.65M4.31M2.46M-
Arcadia Biosciences Total Current Liabilities
Deferred Taxes/Income3.12M2.17M2.31M2.49M2.63M2.78M2.93M3.07M3.63M-
Convertible Debt----------
Long-Term Debt25.12M25.07M25.02M24.97M24.93M19.46M19.34M8.58M8.86M-
Non-Current Capital Leases----------
Other Long-Term Liabilities3M3M3M3M3M3M3M3M3M-
Arcadia Biosciences Total Liabilities
Minority Interest----------
Preferred Stock-------84.57M82.88M-
Common Stock Net0.04M0.04M0.04M0.04M0.04M0.04M0.04M---
Capital Surplus173.72M173.31M172.91M172.58M172.22M171.85M171.33M27.89M29.2M-
Retained Earnings-151.55M-145.84M-141.66M-137.11M-131.92M-128.06M-123.45M-119.77M-113.97M-
Treasury Stock----------
Other Liabilities-0.01M-0.01M-0.01M-0.03M-0.11M-----
Arcadia Biosciences Shareholders Equity
Arcadia Biosciences Total Liabilities & Shareholders Equity
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Balance sheet for another ticker

Looking at Arcadia Biosciences historical stock prices and the current Arcadia Biosciences stock price can tell you how the stock price has moved, whereas the Arcadia Biosciences PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:
  • Assets: An asset is a resource that a corporation like Arcadia Biosciences owns and has monetary significance. RKDA assets decreased from $61.58M in 2016-Q3 to $56.57M in 2016-Q4 . Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. RKDA stock had total liabilities of $34.37M for quarter 2016-Q4.

Arcadia Biosciences Balance Sheet - Key Ratios

Current ratio
Debt to Equity ratio
Asset Turnover
receivables turnover
PB ratio (
price to book ratio

Quarterly Balance Sheets For Arcadia Biosciences Inc Peers

The Andersons balance sheet, DuPont balance sheet, Dow Chemical balance sheet, Monsanto balance sheet